Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.
about
Biochemical properties of the human guanylate binding protein 5 and a tumor-specific truncated splice variantTetramerization of human guanylate-binding protein 1 is mediated by coiled-coil formation of the C-terminal α-helicesTrachoma and Ocular Chlamydial Infection in the Era of GenomicsThe alternative translational profile that underlies the immune-evasive state of persistence in Chlamydiaceae exploits differential tryptophan contents of the protein repertoireDeterminants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control itPathophysiological role of guanylate-binding proteins in gastrointestinal diseasesEvolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune CellsInterferon-induced guanylate-binding proteins in inflammasome activation and host defenseBeyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and ReactivationMutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivity.Cell death of gamma interferon-stimulated human fibroblasts upon Toxoplasma gondii infection induces early parasite egress and limits parasite replicationThe E2-like conjugation enzyme Atg3 promotes binding of IRG and Gbp proteins to Chlamydia- and Toxoplasma-containing vacuoles and host resistance.Dynamins and BAR Proteins-Safeguards against Cancer.Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner.Nucleotide-dependent farnesyl switch orchestrates polymerization and membrane binding of human guanylate-binding protein 1.Interferon-inducible effector mechanisms in cell-autonomous immunity.Nonstructural protein 1 of influenza A virus interacts with human guanylate-binding protein 1 to antagonize antiviral activityGuanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii.Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence FactorsThe secreted kinase ROP18 defends Toxoplasma's border.Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteinsIFN-inducible GTPases in host cell defenseGuanylate-binding protein 1 participates in cellular antiviral response to dengue virus.Modeling the transcriptome of genital tract epithelial cells and macrophages in healthy mucosa versus mucosa inflamed by Chlamydia muridarum infection.Chlamydia persistence -- a tool to dissect chlamydia--host interactions.Guanylate-Binding Protein 1, an Interferon-Induced GTPase, Exerts an Antiviral Activity against Classical Swine Fever Virus Depending on Its GTPase Activity.Suppressor of cytokine signalling protein SOCS1 and UBP43 regulate the expression of type I interferon-stimulated genes in human microvascular endothelial cells infected with Rickettsia conorii.Animal models for studying female genital tract infection with Chlamydia trachomatisHuman GBP1 does not localize to pathogen vacuoles but restricts Toxoplasma gondiiRecombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in miceGamma interferon-induced guanylate binding protein 1 is a novel actin cytoskeleton remodeling factor.Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphataseSensing the enemy, containing the threat: cell-autonomous immunity to Chlamydia trachomatis.Chlamydia-host cell interaction not only from a bird's eye view: some lessons from Chlamydia psittaci.Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins.Immunity-related GTPase M (IRGM) proteins influence the localization of guanylate-binding protein 2 (GBP2) by modulating macroautophagy.Interferon-Inducible GTPases in Host Resistance, Inflammation and Disease.GBP-1 acts as a tumor suppressor in colorectal cancer cells.Processing and secretion of guanylate binding protein-1 depend on inflammatory caspase activity.
P2860
Q24300925-848B3C83-6867-40B1-ABAF-40A401080CFCQ24323235-BCA54CB3-129D-41D9-B2E0-8790049C52C0Q26783635-BC6FC6FC-BAF1-4957-99E2-90080EC11A2EQ26996017-911F94BC-74F1-4EE2-8BEA-DB7CFCAEF69EQ27321401-1246FF9C-77C7-4F11-B4A4-97163917829AQ28078361-37CDD363-BA6A-4FD9-B21B-07ED0B434A4CQ28559840-BE5E7763-4175-46D7-8781-CDF807C8ECCDQ28595838-3EE944A2-6555-455B-B4BA-11CB27D93C2FQ29035294-2E88E736-255D-4F26-82D6-2E7B37F98E88Q30449313-28371020-96F5-44C6-A7C2-C10E060803B4Q30557591-039C2458-1A45-4A0B-B2A3-D5A9C5793B6BQ31148891-44C88FB8-4941-4999-A71E-75553A7562FEQ33699026-F3F23D7B-C6D0-44D7-A494-526B5F9EE34AQ33769297-BF381DE6-7ECA-49A3-B69E-02C54859B334Q33913562-3D7FA09F-8D30-42F7-9F32-1083F07579D4Q34114819-E5EBF9C7-6526-4AFA-9BF4-FD398368752DQ34584607-B638A654-64A3-46BE-84F3-02F775884BA3Q34697891-085882D6-869B-4495-947F-E5113107E6EEQ35710313-2FF4DE5E-5593-4C52-BCF9-CA599DAF1C3EQ36041799-B49B345C-8286-479E-A727-4D77C26175F4Q36179296-790C7FF3-3136-49AF-9979-648700CDBAFFQ36374867-E9BF519A-9633-4ACA-8A95-F8EE372FC30FQ36462912-C2EA1A82-8EB6-4455-B586-5957CEE7D36AQ36517755-22323BE4-BA56-4E22-9B8A-A3351E6294EDQ36795762-9AB3385D-11A9-4C7C-B28F-F5985460081EQ36811907-B3CDAE65-D5A5-4F60-BD80-22AD35FA4031Q37006483-DB7323D7-56EF-45C8-A3B5-D8402027439BQ37123840-CE14D759-4B1B-4B56-BE5A-D5495D2805F6Q37127539-3E3CCD8A-3A9C-4E5A-87F0-85BC0A81408CQ37140167-82FC596B-D7C9-41C0-8AC3-D15CD5C0DE2FQ37546046-9AEA528B-601E-43B4-978C-55716B7E16B0Q37808720-927D485E-4B1D-4AEB-A2BF-D496E1245B3DQ37818303-D36876A5-9AD6-47C4-8A1C-8FBCC603B73FQ37834944-A861F677-1A33-463F-BD06-BD7AE564A344Q37836009-598DD872-AF71-470D-B404-C7D3DC28049BQ37847793-91727FB4-52AA-4FA5-9ED8-28993A2567F3Q38263938-CA14F6D1-569B-47D9-B2B9-FFF736002E43Q38834935-484989CB-C904-4B41-9125-C874B81E13F4Q39264514-02BFE3DD-33AA-47C1-9C90-9F2677B29196Q41520462-B6C425B5-B15C-4085-9607-781B8F8EB05A
P2860
Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Human guanylate binding protei ...... a effects of interferon-gamma.
@ast
Human guanylate binding protei ...... a effects of interferon-gamma.
@en
type
label
Human guanylate binding protei ...... a effects of interferon-gamma.
@ast
Human guanylate binding protei ...... a effects of interferon-gamma.
@en
prefLabel
Human guanylate binding protei ...... a effects of interferon-gamma.
@ast
Human guanylate binding protei ...... a effects of interferon-gamma.
@en
P2860
P1433
P1476
Human guanylate binding protei ...... a effects of interferon-gamma.
@en
P2093
Christelle El-Haibi
Illya Tietzel
P2860
P356
10.1371/JOURNAL.PONE.0006499
P407
P577
2009-08-04T00:00:00Z